Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2009
10/15/2009US20090259043 Tricyclic cytoprotective compounds
10/15/2009US20090259020 Highly fluorinated beta-amino acids and methods of making and using same
10/15/2009US20090259008 Vinyl Monomer And Polymer Derived From The Monomer, And Light Emitting Device Using The Polymer
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258921 Indole derivatives
10/15/2009US20090258919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure
10/15/2009US20090258884 Substituted amides
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP1838670B1 Process for the preparation of carvedilol and its enantiomers
10/14/2009EP1786774B1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009EP1646609B1 Novel chemiluminescent compounds and their use
10/14/2009CN101558039A Carbazolyl monomers and polymers
10/14/2009CN101558038A Novel curcumin derivative
10/14/2009CN100549066C Novel approach to reduce cyclics formation in the production of polyetherimides
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548984C Indole [3,2-b] carbazole derivative organic electroluminescent material
10/14/2009CN100548983C Method for preparing anthracene and carbazole in high purity by rectifying crude anthracene
10/14/2009CN100548982C Heteropolycyclic compound and dye
10/14/2009CN100548981C Processes for the preparation of N-substituted phthalimides
10/14/2009CN100548980C Isoindoline derivative
10/14/2009CN100548979C Process of synthesizing 3-methyl amino indole compound
10/13/2009US7601751 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases
10/13/2009US7601750 Hydroxyalkylindole derivatives as anticancer agents; methyl [3-hydroxymethyl-2-(1-pentyl)-1-(2-phenylethyl)-5-methyl]indole-6-carboxylate, for example
10/13/2009US7601729 Matrix metalloproteinase inhibitors
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2392620C Use of melatonin for the treatment of androgenetic and diffuse alopecia
10/08/2009WO2009123080A1 Indolinone compound
10/08/2009WO2009122425A1 Novel crystalline form of carvedilol dihydrogen phosphate and related processes
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009US20090253916 Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090252678 Cox-2-targeted imaging agents
10/08/2009DE102008017591A1 Neue Materialien für organische Elektrolumineszenzvorrichtungen New materials for organic electroluminescent
10/08/2009CA2720275A1 Indolinone compound
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107053A1 Hydrate crystals of (2R,4R)-Monatin monosodium salt
10/07/2009EP1709027B1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/07/2009EP1537113B1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/07/2009EP1275630B1 Process for producing substituted aromatic compound
10/07/2009EP0741700B1 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
10/07/2009CN101553472A Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
10/07/2009CN101553468A Organic compounds
10/07/2009CN101553467A 5-(heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands
10/07/2009CN101553463A New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof
10/07/2009CN101550102A Method for preparing di-(N-methyl phthalimide) ether
10/07/2009CN101550101A Method for clean purifying L-tryptophan by utilizing fermented liquid
10/07/2009CN101550085A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/06/2009US7598667 which act as hole transporting and luminescent host materials for both fluorescent and phosphorescent emission
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598399 3-Amino-1-arylpropyl substituted heteroaryl compounds usable as monoamine reuptake inhibitors; prepared by hydrogenating an indole propionamide compound with vitride to form an aminopropyl indole compound
10/06/2009US7598398 Acyl indoles, compositions containing such compounds and methods of use
10/06/2009US7598396 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; improves performance characteristics of pharmaceutical product
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598284 Indazole compounds as B3 adrenoceptor agonist
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009US7597955 Light-emitting device, organic compound and display
10/06/2009CA2427617C Medicinal compositions for concomitant use as anticancer agent
10/01/2009WO2009121033A2 Substituted nitrogen heterocycles and synthesis and uses thereof
10/01/2009WO2009120655A1 Indole derivatives
10/01/2009WO2009119163A1 Compound for organic electroluminescent device and organic electroluminescent device using the same
10/01/2009WO2009118753A2 Process for preparation of naratriptan hydrochloride
10/01/2009WO2009118596A2 Phthalimide derivatives as trpa1 modulators
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009118175A1 Novel p2x7r antagonists and their use
10/01/2009WO2009118174A1 Substituted cyclohexyldiamines
10/01/2009WO2009118171A1 Hydroxymethylcyclohexyl amines
10/01/2009WO2009118169A1 Spiro(5.5)undecane derivatives
10/01/2009WO2009118168A1 Substituted 4-aminocyclohexane derivatives
10/01/2009WO2009118163A1 (hetero-)aryl cyclohexane derivatives
10/01/2009WO2009071524A3 Indolinone derivatives and process for their manufacture
10/01/2009WO2009056707A3 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
10/01/2009US20090247784 Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
10/01/2009US20090247768 Crystalline sulfonamide-containing indole compound and process for preparing the same
10/01/2009US20090247766 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
10/01/2009US20090247744 Hydroformylation process for pharmaceutical intermediate
10/01/2009US20090247591 Substituted cyclohexyldiamines
10/01/2009US20090247590 Indane amides
10/01/2009US20090247573 (hetero)aryl cyclohexane derivatives
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247530 Substituted 4-aminocyclohexane derivatives
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247505 Spiro(5.5)undecane derivatives
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2719745A1 Novel p2x7r antagonists and their use
10/01/2009CA2719743A1 Substituted cyclohexyldiamines
10/01/2009CA2719739A1 Hydroxymethylcyclohexylamines
10/01/2009CA2719736A1 Spiro(5.5)undecane derivatives
10/01/2009CA2719735A1 Substituted 4-aminocyclohexane derivatives
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009CA2718209A1 (hetero)aryl cyclohexane derivatives
09/2009
09/30/2009EP2105433A1 Modular scaffold for the design of specific molecules for the use as peptidomimetics and inhibitors of protein interaction
09/30/2009EP2105164A1 Novel P2X7R antagonists and their use
09/30/2009EP1768667B1 Cannabinoid receptor ligands
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 458